Hvis ALT- niveauer øges til 3 X den øvre, normale grænse under Competact- behandling, bør leverenzymniveauerne vurderes igen så hurtigt som muligt.
If ALT levels are increased to 3 X upper limit of normal during Competact therapy, liver enzyme levels should be reassessed as soon as possible.